Explore a new level of precision in drug discovery with Pharmaron’s metabolism services, designed to support your research from early-stage screening through regulatory submission. With over 20 years of experience and cutting-edge metabolite detection technologies, we deliver robust insights into metabolic stability, metabolite profiling, and potential drug-drug interactions.

Key takeaways from this service overview include:

• Flexible Study Designs: From metabolic stability assessments to CYP reversible and time-dependent inhibition studies, our services are tailored to meet diverse project needs.
• Comprehensive Metabolite Profiling: Gain an in-depth understanding of advanced techniques like biomimetic oxidation (BMO) and abundant biological metabolite evaluation (ABME) to generate metabolites for pharmacological and DDI testing.
• Cross-Species Evaluation: Identify species-unique and human-specific metabolites with our detailed preclinical and definitive studies, ensuring regulatory compliance.

Pharmaron’s metabolism services expertise ensures reliable data supporting lead optimization and regulatory submissions.